Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

The New England journal of medicine·2026
Same author

A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study.

American journal of hematology·2025
Same author

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

The New England journal of medicine·2025
Same author

Simulation of Mechanical Stresses in BaTiO<sub>3</sub> Multilayer Ceramic Capacitors during Desoldering in the Rework of Electronic Assemblies Using a Framework of Computational Fluid Dynamics and Thermomechanical Models.

Materials (Basel, Switzerland)·2024
Same author

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report.

Canadian journal of kidney health and disease·2023
Same author

Impact of intraoperative therapeutic plasma exchange on bleeding in lung transplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2023

Related Experiment Video

Updated: Jul 17, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Diagnosing PNH with FLAER and multiparameter flow cytometry.

D Robert Sutherland1, Nancy Kuek, Jeff Davidson

  • 1Clinical Flow Cytometry Laboratory, University Health Network, Toronto, Canada. rob.southerland@utoronto.ca

Cytometry. Part B, Clinical Cytometry
|February 8, 2007
PubMed
Summary

A new FLAER assay improves diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) by detecting minor PNH clones. This flow cytometry method enhances sensitivity for PNH detection in various hematologic disorders.

More Related Videos

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

Related Experiment Videos

Last Updated: Jul 17, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells
10:20

Simultaneous Assessment of Kinship, Division Number, and Phenotype via Flow Cytometry for Hematopoietic Stem and Progenitor Cells

Published on: March 24, 2023

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

Area of Science:

  • Hematology
  • Immunology
  • Cell Biology

Background:

  • Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired stem cell disorder characterized by deficiency of GPI-linked proteins.
  • Diagnosis traditionally involves flow cytometry detecting loss of GPI-linked antigens on blood cells.
  • Existing flow assays have limitations, prompting the development of more sensitive methods.

Purpose of the Study:

  • To develop and validate a FLAER-based flow cytometry assay for diagnosing and monitoring PNH.
  • To enhance the detection of PNH clones, especially minor populations, in patients with other hematologic conditions.

Main Methods:

  • A single-tube assay was developed combining FLAER with CD45, CD33, and CD14.
  • This allowed simultaneous analysis of FLAER and GPI-linked CD14 on neutrophil and monocyte lineages.
  • Assay performance was compared to standard CD55 and CD59 analysis.

Main Results:

  • The FLAER assay demonstrated excellent agreement with standard CD55 and CD59 analysis.
  • Increased sensitivity was observed due to a higher signal-to-noise ratio, enabling detection of PNH clones as small as 1% in aplastic anemia.
  • Abnormal FLAER staining was also noted in blast populations in acute leukemia, suggesting broader utility.

Conclusions:

  • FLAER combined with multiparameter flow cytometry provides an improved method for PNH diagnosis and monitoring.
  • The assay shows potential for detecting unsuspected myeloproliferative disorders and minor PNH clones.